HB 783 seeks to amend Article 8 of Chapter 12 and Chapter 13 of Title 16 of the O.C.G.A. relating to regulation of low THC oil and controlled substances, respectively.

            Article 8 of Chapter 12 is amended through the revision of Code Section 16-12-190 by redefining the term low THC oil to contain cannabidiol and specify the weight of certain substances within the oil.

            Chapter 13 is amended by revising subparagraph (P) and adding new subparagraphs to paragraph (3). This section sees much of its original content removed, and adding the terminology “tetrahydrocannabinol, tetrahydrocannabinolic acid or a combination of tetrahydrocannabinol and tetrahydrocannabinolic acid.”

            Paragraph (12) of Code Section 16-13-25 is revised through the removal and addition of scientific terms relating to Schedule I controlled substances. Code Section 16-13-28 is also revised to adjust the compounds within the classification Schedule IV controlled substances. Code Section 16-13-71 is further amended in a similar manner, as well as redefines the term “dangerous drug.”

            Code Section 16-13-79 relating to violations of the “Dangerous Drug Act” adds section (e) which mandates that any person who knowingly distributes or resells any nonprescription injectable insulin product which was first obtained through over-the-counter sales made to a patient from any pharmacy, practitioner, or other source shall be guilty of a misdemeanor. Any of such drug sold in this manner shall be considered to be an adulterated dangerous drug and unsalable, making it subject to seizure under the laws of this state.